An interventional study of High-Intensity Interval Training (HIIT) in Obese Adults, sponsored by Universidad Nacional Andres Bello. Not yet recruiting at 1 site in Chile. Open to participants aged 20 Years to 39 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Universidad Nacional Andres Bello · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 54 studies in Motor Activity with a site in Chile — 17 open to participants now, 20 under way, none of them phase 3. Motor Activity · Chile.
Among the 54 studies in Motor Activity with a site in Chile, this one is the 48th largest by planned enrollment of the 50 interventional ones that give a count, is one of 6 that started in 2026, is one of 49 with no phase, reaches primary completion later than 18 of the 19 other live ones, and was the 54th registered.
9,824 studies on the registry are indexed under Motor Activity; 1,917 are open to participants now.
Browse Motor Activity studies →17 of the 54 studies in Motor Activity with a site in Chile are open now. Recruiting first, the newest first:
University of Chile · Sites in Chile
Ages 55–75
Universidad San Sebastián · Sites in Chile
Ages 18–59
Pontificia Universidad Catolica de Chile · Sites in Chile
Ages 18–40 · Healthy volunteers
University of Chile · Sites in Chile
Ages 65+
Universidad de La Frontera · Sites in Chile
Ages 18+
A study can be open while its sites in Chile have not opened yet or have stopped. Only those recruiting at a site in Chile →
Of the 1,210 Motor Activity studies recruiting now, 522 (43%) set no upper age limit and 540 (45%) stop at 75 or younger; 180 take children under 18; 422 take healthy volunteers.
This study: 20 Years to 39 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
54 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 6 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 17 is below the median of 60 across 8,409 interventional studies indexed under Motor Activity.
Median enrollment 60 across the 50 interventional studies, 1,434 across the 4 observational. Of the 26 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 54 has an industry lead sponsor. The 10 most frequent:
Universidad Nacional Andres Bello is the lead sponsor of 24 studies on the registry; 11 are open to participants now.
Universidad Nacional Andres Bello has 1 study filed under Motor Activity — fewer than ten, so there is no comparison to draw.
4 of the studies in Motor Activity with a site in Chile that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06698367Universidad Catolica de TemucoUnilateral Training of the Uninjured Limb on Clinical Outcomes in Patients with Surgically Treated Radius Fracture | 2026-12 |
| NCT07552727Universidad San SebastiánRehabilitation With Exercise-Based Intervention for Nonalcoholic Chronic Hepatic Esteatosis | 2026-12-31 |
| NCT07633392University of ChileEffectiveness and Implementation Evaluation of NeoMayor for Improving Cardiovascular Health in Chilean Older Adults | 2027-04 |
| NCT07944456Universidad Nacional Andres BelloHigh-Intensity Interval Training, Inflammatory Biomarkers, and Circulating MicroRNAs in Human Clinical Obesity. | 2027-06 |
Add all 4 to your calendar (.ics) → With an account.
Among the 54 studies in Motor Activity with a site in Chile, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This randomized controlled trial evaluates the effects of high-intensity interval training (HIIT) on body composition, inflammatory biomarkers, and circulating microRNAs in adults with clinical obesity. Circulating microRNAs are small regulatory molecules that may reflect exercise-induced adaptations and inter-tissue communication related to skeletal muscle and metabolic health. The study investigates whether exercise-induced changes in adiposity are accompanied by changes in inflammatory status and circulating microRNA profiles associated with skeletal muscle adaptations and metabolic health.
Clinical obesity is characterized by excessive adiposity accompanied by impaired metabolic health and chronic low-grade inflammation. Emerging evidence suggests that obesity is also associated with alterations in circulating molecular biomarkers that may influence skeletal muscle function and inter-tissue communication.
High-intensity interval training (HIIT) is an effective exercise strategy for improving body composition and cardiometabolic health; however, the molecular mechanisms underlying these adaptations remain incompletely understood. In particular, limited information is available regarding the response of circulating muscle-related microRNAs (myomiRs) to exercise interventions in adults with clinical obesity.
This randomized controlled trial is designed to investigate physiological and molecular adaptations to HIIT in adults with clinical obesity. The study will examine the relationship between changes in adiposity, systemic inflammation, and circulating microRNA expression following a supervised exercise intervention. Circulating microRNAs may provide insight into exercise-responsive biological pathways and represent potential biomarkers of skeletal muscle adaptation and metabolic health.
The findings may improve understanding of the molecular mechanisms associated with exercise-induced health benefits in clinical obesity and contribute to the identification of novel biomarkers relevant to obesity management and precision exercise medicine.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants assigned to this arm will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during 8 weeks. Each training session will last approximately 30 minutes and include a warm-up, high-intensity intervals performed at approximately 90% of maximal power output, active recovery periods, and a cool-down. All sessions will be supervised by qualified personnel to ensure participant safety and adherence to the protocol.
Behavioral: High-Intensity Interval Training (HIIT)
Participants assigned to this arm will maintain their habitual lifestyle without participating in a structured exercise program during the intervention period. Educational materials on healthy lifestyle habits will be provided at the end of the study.
Participants will complete a supervised high-intensity interval training (HIIT) program performed on a cycle ergometer three times per week during eight weeks. Each session will last approximately 30 minutes and consist of a warm-up, ten 1-minute high-intensity intervals performed at approximately 90% of maximal power output, interspersed with 1-minute active recovery periods, and a cool-down. Training intensity will be reassessed midway through the intervention to ensure appropriate progression. All sessions will be supervised by qualified personnel to promote adherence, proper exercise execution, and participant safety.
Total Body Fat Mass Assessed by Bioelectrical Impedance Analysis
Total body fat mass (kg) will be assessed using bioelectrical impedance analysis and compared between baseline and post-intervention measurements.
Time frame: Change from baseline to Week 8
Plasma Interleukin-1β (IL-1β) and Tumor Necrosis Factor-α (TNF-α) concentration Assessed by ELISA
Plasma IL-1β concentration (pg/mL) and TNF-α concentration (pg/mL) measured by enzyme-linked immunosorbent assay (ELISA).
Time frame: From baseline to Week 8
Circulating Myo-MicroRNAs
Change in circulating expression of miR-1, miR-133, and miR-206 quantified by RT-qPCR.
Time frame: from enrollment to the end of treatment at 8 weeks
Peak Oxygen Uptake (VO₂peak)
Change in cardiorespiratory fitness assessed by peak oxygen uptake during an incremental cycling test.
Time frame: From baseline to Week 8
Handgrip Strength
Change in maximal handgrip strength assessed using a hydraulic hand dynamometer.
Time frame: From baseline to Week 8
Maximal Voluntary Isometric Contraction (MVC)
Change in maximal isometric strength of the knee extensor muscles measured by dynamometry.
Time frame: From baseline to Week 8
Health-Related Quality of Life Assessed Using the 36-Item Short Form Health Survey (SF-36)
Change in health-related quality of life assessed using the 36-Item Short Form Health Survey (SF-36). Scores range from 0 to 100, with higher scores indicating better perceived health status and quality of life.
Time frame: From baseline to Week 8
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Jun 2027, 7 months later.
Of 5,170 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 7 months is below that.
Counting every sponsor, half of 5,230 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Nacional Andres Bello